TY - JOUR
T1 - Blood Flow Quantification with High-Frame-Rate, Contrast-Enhanced Ultrasound Velocimetry in Stented Aortoiliac Arteries
T2 - In Vivo Feasibility
AU - Engelhard, Stefan
AU - van Helvert, Majorie
AU - Voorneveld, Jason
AU - Bosch, Johan G.
AU - Lajoinie, Guillaume
AU - Jebbink, Erik Groot
AU - Reijnen, Michel M.P.J.
AU - Versluis, Michel
N1 - Funding Information:
The authors thank Bastiaan Bongers, Laura Bouwmeister, Jochem Noordzij, Pinel Schrijver and Frans Tak for their assistance during the high-frame-rate contrast-enhanced US measurements. This work was supported by a private charitable organization, the Lijf en Leven Foundation, based in Krimpen aan den IJssel, The Netherlands.
Publisher Copyright:
© 2022 The Authors
PY - 2022/8
Y1 - 2022/8
N2 - Local flow patterns influence stent patency, while blood flow quantification in stents is challenging. The aim of this study was to investigate the feasibility of 2-D blood flow quantification using high-frame-rate, contrast-enhanced ultrasound (HFR-CEUS) and particle image velocimetry (PIV), or echoPIV, in patients with aortoiliac stents. HFR-CEUS measurements were performed at 129 locations in 62 patients. Two-dimensional blood flow velocity fields were obtained using echoPIV. Visual inspection was performed by five observers to evaluate feasibility. The contrast-to-background ratio and average vector correlation were calculated and compared between stented and native vessel segments. Flow quantification with echoPIV was feasible in 128 of 129 locations (99%), with optimal quantification in 40 of 129 locations (31%). Partial quantification was achieved in 88 of 129 locations (68%), where one or multiple limiting issues occurred (not related to the stent) including loss of correlation during systole (57/129), short vessel segments (20/129), loss of contrast during diastole (20/129) and shadow regions (20/129). The contrast-to-background ratio and vector correlation were lower downstream in the imaged blood vessel, independent of the location of the stent. In conclusion, echoPIV was feasible in stents placed in the aortoiliac region, and the stents did not adversely affect flow tracking.
AB - Local flow patterns influence stent patency, while blood flow quantification in stents is challenging. The aim of this study was to investigate the feasibility of 2-D blood flow quantification using high-frame-rate, contrast-enhanced ultrasound (HFR-CEUS) and particle image velocimetry (PIV), or echoPIV, in patients with aortoiliac stents. HFR-CEUS measurements were performed at 129 locations in 62 patients. Two-dimensional blood flow velocity fields were obtained using echoPIV. Visual inspection was performed by five observers to evaluate feasibility. The contrast-to-background ratio and average vector correlation were calculated and compared between stented and native vessel segments. Flow quantification with echoPIV was feasible in 128 of 129 locations (99%), with optimal quantification in 40 of 129 locations (31%). Partial quantification was achieved in 88 of 129 locations (68%), where one or multiple limiting issues occurred (not related to the stent) including loss of correlation during systole (57/129), short vessel segments (20/129), loss of contrast during diastole (20/129) and shadow regions (20/129). The contrast-to-background ratio and vector correlation were lower downstream in the imaged blood vessel, independent of the location of the stent. In conclusion, echoPIV was feasible in stents placed in the aortoiliac region, and the stents did not adversely affect flow tracking.
KW - Aortoiliac occlusive disease
KW - Arterial stenting
KW - Contrast-enhanced ultrasound
KW - Endovascular treatment
KW - High frame rate
KW - Particle image velocimetry
KW - UT-Hybrid-D
UR - http://www.scopus.com/inward/record.url?scp=85130327683&partnerID=8YFLogxK
U2 - 10.1016/j.ultrasmedbio.2022.03.016
DO - 10.1016/j.ultrasmedbio.2022.03.016
M3 - Article
C2 - 35577661
AN - SCOPUS:85130327683
SN - 0301-5629
VL - 48
SP - 1518
EP - 1527
JO - Ultrasound in medicine and biology
JF - Ultrasound in medicine and biology
IS - 8
ER -